$ALXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALEXION PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALEXION PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 16 17 18 19 20 21 22 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 11 2006 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Grant | A | 0.00 | 3,706 | 0 | 27,706 | 24 K to 27.7 K (+15.44 %) |
Apr 11 2006 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Grant | A | 0.00 | 3,721 | 0 | 11,721 | 8 K to 11.7 K (+46.51 %) |
Apr 11 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 0.00 | 4,272 | 0 | 12,272 | 8 K to 12.3 K (+53.40 %) |
Apr 11 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Grant | A | 0.00 | 5,409 | 0 | 96,418 | 91 K to 96.4 K (+5.94 %) |
Apr 11 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Grant | A | 0.00 | 10,088 | 0 | 321,599 | 311.5 K to 321.6 K (+3.24 %) |
Mar 14 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | M | 10.00 | 3,005 | 30,050 | 0 | |
Mar 14 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 38.35 | 3,005 | 115,242 | 91,009 | 94 K to 91 K (-3.20 %) |
Mar 14 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Buy | M | 10.00 | 3,005 | 30,050 | 94,014 | 91 K to 94 K (+3.30 %) |
Mar 14 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 10.00 | 8,907 | 89,070 | 0 | |
Mar 14 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 38.35 | 8,907 | 341,583 | 311,511 | 320.4 K to 311.5 K (-2.78 %) |
Mar 14 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 10.00 | 8,907 | 89,070 | 320,418 | 311.5 K to 320.4 K (+2.86 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.50 | 5,000 | 52,500 | 11,875 | |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.08 | 100 | 3,508 | 8,000 | 8.1 K to 8 K (-1.23 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.06 | 500 | 17,531 | 8,100 | 8.6 K to 8.1 K (-5.81 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.06 | 500 | 17,530 | 8,600 | 9.1 K to 8.6 K (-5.49 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.05 | 948 | 33,227 | 9,100 | 10 K to 9.1 K (-9.43 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 35.00 | 2,952 | 103,320 | 10,048 | 13 K to 10 K (-22.71 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.50 | 5,000 | 52,500 | 13,000 | 8 K to 13 K (+62.50 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 10.00 | 10,000 | 100,000 | 783 | |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 35.01 | 10,000 | 350,100 | 311,511 | 321.5 K to 311.5 K (-3.11 %) |
Feb 21 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 10.00 | 10,000 | 100,000 | 321,511 | 311.5 K to 321.5 K (+3.21 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | M | 10.00 | 20,000 | 200,000 | 3,005 | |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 30.15 | 240 | 7,236 | 91,009 | 91.2 K to 91 K (-0.26 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 30.16 | 240 | 7,238 | 91,249 | 91.5 K to 91.2 K (-0.26 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 30.17 | 480 | 14,482 | 91,489 | 92 K to 91.5 K (-0.52 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 30.19 | 80 | 2,415 | 91,969 | 92 K to 92 K (-0.09 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 30.20 | 3,198 | 96,580 | 92,049 | 95.2 K to 92 K (-3.36 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 30.21 | 80 | 2,417 | 95,247 | 95.3 K to 95.2 K (-0.08 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 30.22 | 8,160 | 246,595 | 95,327 | 103.5 K to 95.3 K (-7.89 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Sell | S | 30.23 | 7,522 | 227,390 | 103,487 | 111 K to 103.5 K (-6.78 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Buy | M | 10.00 | 20,000 | 200,000 | 111,009 | 91 K to 111 K (+21.98 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 10.00 | 15,000 | 150,000 | 10,783 | |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 30.15 | 60 | 1,809 | 311,511 | 311.6 K to 311.5 K (-0.02 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 30.16 | 60 | 1,810 | 311,571 | 311.6 K to 311.6 K (-0.02 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 30.17 | 120 | 3,620 | 311,631 | 311.8 K to 311.6 K (-0.04 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 30.19 | 20 | 604 | 311,751 | 311.8 K to 311.8 K (-0.01 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 30.20 | 799 | 24,130 | 311,771 | 312.6 K to 311.8 K (-0.26 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 30.21 | 20 | 604 | 312,570 | 312.6 K to 312.6 K (-0.01 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 30.22 | 2,040 | 61,649 | 312,590 | 314.6 K to 312.6 K (-0.65 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 30.23 | 1,881 | 56,863 | 314,630 | 316.5 K to 314.6 K (-0.59 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 29.55 | 7,700 | 227,535 | 316,511 | 324.2 K to 316.5 K (-2.37 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 29.60 | 2,300 | 68,080 | 324,211 | 326.5 K to 324.2 K (-0.70 %) |
Feb 03 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 10.00 | 15,000 | 150,000 | 326,511 | 311.5 K to 326.5 K (+4.82 %) |
Feb 01 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 10.00 | 10,000 | 100,000 | 25,783 | |
Feb 01 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 28.40 | 10,000 | 284,000 | 311,511 | 321.5 K to 311.5 K (-3.11 %) |
Feb 01 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 10.00 | 10,000 | 100,000 | 321,511 | 311.5 K to 321.5 K (+3.21 %) |
Jan 11 2006 | ALXN | ALEXION PHARMACEUT ... | Waeger Ruedi E | Director | Grant | A | 20.72 | 2,000 | 41,440 | 2,000 | 0 to 2 K |
Jan 11 2006 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Grant | A | 20.72 | 2,000 | 41,440 | 2,000 | 0 to 2 K |
Jan 11 2006 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Grant | A | 20.72 | 2,000 | 41,440 | 3,049 | 1 K to 3 K (+190.66 %) |
Jan 11 2006 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Grant | A | 20.72 | 2,000 | 41,440 | 5,000 | 3 K to 5 K (+66.67 %) |
Jan 11 2006 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Grant | A | 20.72 | 2,000 | 41,440 | 57,000 | 55 K to 57 K (+3.64 %) |
Jan 11 2006 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Grant | A | 20.72 | 2,000 | 41,440 | 62,157 | 60.2 K to 62.2 K (+3.32 %) |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Option Exercise | A | 20.72 | 10,000 | 207,200 | 10,000 | |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Grant | A | 20.72 | 4,000 | 82,880 | 24,000 | 20 K to 24 K (+20.00 %) |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | Coissac Patrice | GM/President-ALXN E ... | Option Exercise | A | 20.72 | 8,000 | 165,760 | 8,000 | |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | Coissac Patrice | GM/President-ALXN E ... | Grant | A | 20.72 | 3,000 | 62,160 | 13,000 | 10 K to 13 K (+30.00 %) |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | A | 20.72 | 8,000 | 165,760 | 8,000 | |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Grant | A | 20.72 | 3,000 | 62,160 | 6,000 | 3 K to 6 K (+100.00 %) |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | A | 20.72 | 8,000 | 165,760 | 8,000 | |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Grant | A | 20.72 | 3,000 | 62,160 | 18,000 | 15 K to 18 K (+20.00 %) |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 20.72 | 10,000 | 207,200 | 10,000 | |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 20.72 | 4,000 | 82,880 | 8,000 | 4 K to 8 K (+100.00 %) |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | A | 20.72 | 10,000 | 207,200 | 10,000 | |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Grant | A | 20.72 | 4,000 | 82,880 | 91,009 | 87 K to 91 K (+4.60 %) |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | A | 20.72 | 24,500 | 507,640 | 24,500 | |
Jan 10 2006 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Grant | A | 20.72 | 11,250 | 233,100 | 311,511 | 300.3 K to 311.5 K (+3.75 %) |
Dec 13 2005 | ALXN | ALEXION PHARMACEUT ... | Waeger Ruedi E | Director | Option Exercise | A | 19.73 | 7,500 | 147,975 | 7,500 | |
Dec 13 2005 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | A | 19.73 | 7,500 | 147,975 | 7,500 | |
Dec 13 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | A | 19.73 | 7,500 | 147,975 | 7,500 | |
Dec 13 2005 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 19.73 | 7,500 | 147,975 | 7,500 | |
Dec 13 2005 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 19.73 | 7,500 | 147,975 | 7,500 | |
Dec 13 2005 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Option Exercise | A | 19.73 | 7,500 | 147,975 | 7,500 | |
Nov 09 2005 | ALXN | ALEXION PHARMACEUT ... | Coissac Patrice | GM/President-ALXN E ... | Option Exercise | A | 28.16 | 20,000 | 563,200 | 20,000 | |
Nov 09 2005 | ALXN | ALEXION PHARMACEUT ... | Coissac Patrice | GM/President-ALXN E ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Nov 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 10.00 | 5,000 | 50,000 | 35,783 | |
Nov 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.00 | 5,000 | 135,000 | 300,261 | 305.3 K to 300.3 K (-1.64 %) |
Nov 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 10.00 | 5,000 | 50,000 | 305,261 | 300.3 K to 305.3 K (+1.67 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.94 | 400 | 10,776 | 57,657 | 57.3 K to 57.7 K (+0.70 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.93 | 1,040 | 28,007 | 57,257 | 56.2 K to 57.3 K (+1.85 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.92 | 100 | 2,692 | 56,217 | 56.1 K to 56.2 K (+0.18 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.90 | 100 | 2,690 | 56,117 | 56 K to 56.1 K (+0.18 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.89 | 160 | 4,302 | 56,017 | 55.9 K to 56 K (+0.29 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.86 | 100 | 2,686 | 55,857 | 55.8 K to 55.9 K (+0.18 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.85 | 300 | 8,055 | 55,757 | 55.5 K to 55.8 K (+0.54 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.84 | 100 | 2,684 | 55,457 | 55.4 K to 55.5 K (+0.18 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.83 | 300 | 8,049 | 55,357 | 55.1 K to 55.4 K (+0.54 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.82 | 6,000 | 160,920 | 55,057 | 49.1 K to 55.1 K (+12.23 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.81 | 100 | 2,681 | 49,057 | 49 K to 49.1 K (+0.20 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.80 | 200 | 5,360 | 48,957 | 48.8 K to 49 K (+0.41 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.79 | 500 | 13,395 | 48,757 | 48.3 K to 48.8 K (+1.04 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.78 | 100 | 2,678 | 48,257 | 48.2 K to 48.3 K (+0.21 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.74 | 100 | 2,674 | 48,157 | 48.1 K to 48.2 K (+0.21 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.73 | 100 | 2,673 | 48,057 | 48 K to 48.1 K (+0.21 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.71 | 500 | 13,355 | 47,957 | 47.5 K to 48 K (+1.05 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.70 | 700 | 18,690 | 47,457 | 46.8 K to 47.5 K (+1.50 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.68 | 100 | 2,668 | 46,757 | 46.7 K to 46.8 K (+0.21 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.67 | 100 | 2,667 | 46,657 | 46.6 K to 46.7 K (+0.21 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.66 | 500 | 13,330 | 46,557 | 46.1 K to 46.6 K (+1.09 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.65 | 400 | 10,660 | 46,057 | 45.7 K to 46.1 K (+0.88 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.64 | 300 | 7,992 | 45,657 | 45.4 K to 45.7 K (+0.66 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.63 | 300 | 7,989 | 45,357 | 45.1 K to 45.4 K (+0.67 %) |
Oct 11 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 26.62 | 2,400 | 63,888 | 45,057 | 42.7 K to 45.1 K (+5.63 %) |
Nov 02 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | D | 21.76 | 2,500 | 54,400 | 0 | |
Nov 02 2005 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 21.76 | 2,500 | 54,400 | 60,157 | 57.7 K to 60.2 K (+4.34 %) |
Oct 31 2005 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | P | 26.26 | 1,000 | 26,255 | 3,000 | 2 K to 3 K (+50.00 %) |
Oct 17 2005 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | P | 26.74 | 225 | 6,017 | 1,049 | 824 to 1 K (+27.31 %) |
Oct 17 2005 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | P | 26.74 | 824 | 22,034 | 824 | 0 to 824 |
Oct 07 2005 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | P | 26.52 | 1,000 | 26,520 | 2,000 | 1,000 to 2 K (+100.00 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | M | 10.00 | 5,568 | 55,680 | 0 | |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Buy | M | 10.00 | 5,568 | 55,680 | 87,009 | 81.4 K to 87 K (+6.84 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Payment of Exercise | F | 28.03 | 1,986 | 55,668 | 81,441 | 83.4 K to 81.4 K (-2.38 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 10.00 | 5,000 | 50,000 | 40,783 | |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.50 | 2,600 | 71,500 | 300,261 | 302.9 K to 300.3 K (-0.86 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.51 | 800 | 22,008 | 302,861 | 303.7 K to 302.9 K (-0.26 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.52 | 100 | 2,752 | 303,661 | 303.8 K to 303.7 K (-0.03 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.54 | 700 | 19,278 | 303,761 | 304.5 K to 303.8 K (-0.23 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.55 | 300 | 8,265 | 304,461 | 304.8 K to 304.5 K (-0.10 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.56 | 100 | 2,756 | 304,761 | 304.9 K to 304.8 K (-0.03 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.58 | 300 | 8,274 | 304,861 | 305.2 K to 304.9 K (-0.10 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 27.59 | 100 | 2,759 | 305,161 | 305.3 K to 305.2 K (-0.03 %) |
Oct 04 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 10.00 | 5,000 | 50,000 | 305,261 | 300.3 K to 305.3 K (+1.67 %) |
Sep 22 2005 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | SVP Clinical Develo ... | Option Exercise | A | 27.58 | 6,000 | 165,480 | 6,000 | |
Sep 23 2005 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Option Exercise | A | 27.58 | 85,000 | 2,344,300 | 85,000 | |
Sep 23 2005 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & Chief Financi ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Sep 22 2005 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | SVP & General Couns ... | Option Exercise | A | 27.58 | 6,000 | 165,480 | 6,000 | |
Sep 22 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 27.58 | 8,000 | 220,640 | 8,000 | |
Sep 22 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | A | 27.58 | 8,000 | 220,640 | 8,000 | |
Sep 07 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Option Exercise | M | 10.00 | 21,427 | 214,270 | 5,568 | |
Sep 07 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Buy | M | 10.00 | 21,427 | 214,270 | 83,427 | 62 K to 83.4 K (+34.56 %) |
Sep 07 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & COO | Payment of Exercise | F | 28.57 | 7,500 | 214,275 | 62,000 | 69.5 K to 62 K (-10.79 %) |
Sep 22 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | A | 27.58 | 22,500 | 620,550 | 22,500 | |
Sep 01 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 10.00 | 5,000 | 50,000 | 45,783 | |
Sep 01 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 28.70 | 5,000 | 143,500 | 300,261 | 305.3 K to 300.3 K (-1.64 %) |
Sep 01 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 10.00 | 5,000 | 50,000 | 305,261 | 300.3 K to 305.3 K (+1.67 %) |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 10.00 | 11,093 | 110,930 | 0 | |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 10.00 | 5,000 | 50,000 | 50,783 | |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 10.00 | 11,093 | 110,930 | 300,261 | 289.2 K to 300.3 K (+3.84 %) |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Payment of Exercise | F | 26.24 | 4,227 | 110,916 | 289,168 | 293.4 K to 289.2 K (-1.44 %) |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 26.05 | 3,132 | 81,589 | 293,395 | 296.5 K to 293.4 K (-1.06 %) |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 26.10 | 1,468 | 38,315 | 296,527 | 298 K to 296.5 K (-0.49 %) |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 26.11 | 100 | 2,611 | 297,995 | 298.1 K to 298 K (-0.03 %) |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 26.12 | 200 | 5,224 | 298,095 | 298.3 K to 298.1 K (-0.07 %) |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 26.14 | 100 | 2,614 | 298,295 | 298.4 K to 298.3 K (-0.03 %) |
Aug 03 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 10.00 | 5,000 | 50,000 | 298,395 | 293.4 K to 298.4 K (+1.70 %) |
Jul 18 2005 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP, Finance & Admin ... | Option Exercise | M | 10.00 | 15,000 | 150,000 | 10,000 | |
Jul 18 2005 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP, Finance & Admin ... | Sell | S | 24.88 | 2,500 | 62,209 | 24,800 | 27.3 K to 24.8 K (-9.16 %) |
Jul 18 2005 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP, Finance & Admin ... | Sell | S | 24.86 | 2,500 | 62,156 | 27,300 | 29.8 K to 27.3 K (-8.39 %) |
Jul 18 2005 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP, Finance & Admin ... | Sell | S | 24.78 | 5,000 | 123,892 | 29,800 | 34.8 K to 29.8 K (-14.37 %) |
Jul 18 2005 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP, Finance & Admin ... | Sell | S | 24.75 | 5,000 | 123,750 | 34,800 | 39.8 K to 34.8 K (-12.56 %) |
Jul 18 2005 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP, Finance & Admin ... | Buy | M | 10.00 | 15,000 | 150,000 | 39,800 | 24.8 K to 39.8 K (+60.48 %) |